Skip to main content

Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity

Healthcare
United States
Started March 14, 2026

Daisy Wolf speaks with Dr. Andrew Huberman, professor of neurobiology and ophthalmology at Stanford University and host of the Huberman Lab podcast. They discuss how the pandemic sparked a consumer health revolution, the emerging peptide and GLP landscape, what the science actually says about focus drugs, and the neurotechnologies Huberman believes will let us write to our own biology within the next five years

🗳️ Join the conversation
5 statements to vote on • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (7+ recommended) 5/7
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM Posted by will Mar 14, 2026
While focus drugs may enhance productivity, their long-term effects on mental health and societal norms should be critically examined.
0 total votes
CLAIM Posted by will Mar 14, 2026
The enthusiasm for sleep tech and neuroenhancements may overshadow the importance of fundamental lifestyle changes in achieving health.
0 total votes
CLAIM Posted by will Mar 14, 2026
The rise of peptide therapies represents a groundbreaking advancement in personalized medicine that could revolutionize obesity treatment.
0 total votes
CLAIM Posted by will Mar 14, 2026
Relying on neurotechnology to alter our biology risks oversimplifying complex health issues and could lead to unforeseen consequences.
0 total votes
CLAIM Posted by will Mar 14, 2026
The consumer health revolution sparked by the pandemic empowers individuals to take charge of their wellness through innovative technologies and treatments.
0 total votes

💡 How This Works

  • Add Statements: Post claims or questions (10-500 characters)
  • Vote: Agree, Disagree, or Unsure on each statement
  • Respond: Add detailed pro/con responses with evidence
  • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us